Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Intertek profit margin declines despite 10 per cent rise in revenue

Fri, 17th May 2013 07:01

Intertek Group, which provides solutions to industries worldwide, has posted a 9.9 per cent year-on-year rise in revenue for the first four months of the year, driven by organic growth, favourable currency movements and the benefit of acquisitions made in 2012 and 2013. However, the group's operating profit margin is below the level seen last year following the impact of the sharp profit decline in the minerals business. This minerals decline is now expected to continue into the second half of the year as that sector overall experiences a more prolonged downturn.Divisionally, in Commodities, revenue from minerals, especially in Australia, Brazil and the Philippines, declined more sharply than the company had expected. This was primarily as a result of a reduction in mining activities leading to lower sample volumes and price competition. The decline follows strong growth in the prior year and is characteristic of this more cyclical industry. Oil cargo inspection grew well in the period, the group said.Industry & Assurance saw the technical inspection of energy assets grew well, driven mainly by capital investment going into the oil, gas, power and renewables industries, whilst growth from Business Assurance was weaker.Within Consumer Goods, growth in textiles continued to be "strong", with good demand also in factory auditing services. The firm said Toys and hardlines were flat, whilst awaiting an improvement in trading from a tighter regulatory environment expected for the mid-year buying season.In Commercial & Electrical, it said the increased investments made in 2012 are ramping up and starting to have a positive effect on the volume of testing. Electric vehicles and lighting continued to register strong growth, however slower demand in some European countries for electrical testing, a weaker renewable market and strong comparables for medical device testing as a result of new regulations in 2012 moderated the division's overall growth rate.Chemicals & Pharmaceuticals had a mixed start to the year with health, environmental and regulatory and pharmaceutical services growth being much stronger than chemicals and materials.Wolfhart Hauser, Chief Executive Officer of Intertek, said: "Revenue grew well overall in the period against high comparable growth from last year and in a more variable economic environment than we had expected at the beginning of the year. "Looking ahead, whilst we expect the margin drag from the minerals business to reduce in the second half, its effect is expected to leave full year group margin broadly stable with the prior year."NR

Related Shares

More News
15 Apr 2024 09:49

LONDON BROKER RATINGS: UBS raises Crest Nicholson; Stifel cuts CRH

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

26 Mar 2024 09:40

LONDON BROKER RATINGS: Dr Martens cut to 'sell'; BofA likes Tullow

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

25 Mar 2024 10:19

LONDON BROKER RATINGS: SocGen raises Sage; Numis cuts Virgin Money

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of in...

15 Mar 2024 08:02

Shore Capital downgrades Intertek to 'sell'

(Sharecast News) - Analysts at Shore Capital downgraded Intertek from 'hold' to 'sell' on Friday following the group's recent results.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.